CrystalGenomics, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Seongnam Korea, Republic of (2000)

Organization Overview

First Clinical Trial
2007
NCT00530452
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CrystalGenomics, Inc.